Guanosine exerts neuroprotective effects by reversing mitochondrial dysfunction in a cellular model of Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  International Journal of Molecular Medicine

• Publication date

  2014-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/ijmm.2014.1904PMID 25174304
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of glycogen synthase kinase-3β with Parkinson’s disease (Review)

  2014cited by this paper
• α-lipoic acid protects dopaminergic neurons against MPP+-induced apoptosis by attenuating reactive oxygen species formation.

  2013cited by this paper
• [Epidemiology of Parkinson's disease].

  2013cited by this paper
• PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial translocation of Parkin and regulates mitophagy

  2012cited by this paper
• Neuroprotective effect of guanosine against glutamate‐induced cell death in rat hippocampal slices is mediated by the phosphatidylinositol‐3 kinase/Akt/ glycogen synthase kinase 3β pathway activation and inducible nitric oxide synthase inhibition

  2011cited by this paper
• Guanosine is neuroprotective against oxygen/glucose deprivation in hippocampal slices via large conductance Ca²+-activated K+ channels, phosphatidilinositol-3 kinase/protein kinase B pathway activation and glutamate uptake.

  2011cited by this paper
• Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases

  2010cited by this paper
• Guanosine protects human neuroblastoma cells from oxidative stress and toxicity induced by Amyloid-beta peptide oligomers.

  2010cited by this paper
• Human brain cortex: mitochondrial oxidative damage and adaptive response in Parkinson disease and in dementia with Lewy bodies.

  2009cited by this paper
• The undertow of sulfur metabolism on glutamatergic neurotransmission.

  2008cited by this paper
• Glial reactions in Parkinson's disease

  2008cited by this paper
• Oxidative Stress in Parkinson's Disease

  2008cited by this paper
• Neuroprotective effects of guanosine on stroke models in vitro and in vivo.

  2008cited by this paper
• Caspase function in programmed cell death

  2007cited by this paper
• Protective Effect of Glycyrrhizin on 1-Methyl-4-phenylpyridinium-Induced Mitochondrial Damage and Cell Death in Differentiated PC12 Cells

  2007cited by this paper
• MPP+-induced cytotoxicity in neuroblastoma cells: Antagonism and reversal by guanosine

  2007cited by this paper
• The pathogenesis of cell death in Parkinson's disease – 2007

  2007cited by this paper
• Mitochondrial membrane permeabilization: the sine qua non for cell death.

  2006cited by this paper
• Expanding insights of mitochondrial dysfunction in Parkinson's disease

  2006cited by this paper
• Epidemiology of Parkinson's disease.

  2006cited by this paper
• The pathogenesis of cell death in Parkinson's disease

  2006cited by this paper
• Glycogen synthase kinase-3beta/beta-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium.

  2006cited by this paper
• Oxidative stress and neurodegeneration: where are we now?

  2006cited by this paper
• A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine

  2005cited by this paper
• Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage.

  2005cited by this paper
• Guanosine protects SH-SY5Y cells against &bgr;-amyloid-induced apoptosis

  2004cited by this paper
• Bcl-2 family regulation of neuronal development and neurodegeneration.

  2004cited by this paper
• The antiapoptotic effect of guanosine is mediated by the activation of the PI 3‐kinase/AKT/PKB pathway in cultured rat astrocytes

  2004cited by this paper
• Neurological diseases: Targeting programmed cell death in neurodegenerative diseases

  2003cited by this paper
• Many cuts to ruin: a comprehensive update of caspase substrates

  2003cited by this paper
• Mechanisms of caspase activation.

  2003cited by this paper
• Changes in mitochondrial membrane potential and mitochondrial mass occur independent of the activation of caspase-8 and caspase-3 during CD95-mediated apoptosis in peripheral blood T cells.

  2003cited by this paper
• PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers

  2002cited by this paper
• Neuroprotective effects of lithium in cultured cells and animal models of diseases.

  2002cited by this paper
• Breaking the mitochondrial barrier

  2001cited by this paper
• Effect of MPTP‐induced denervation on basal ganglia GABAB receptors: Correlation with dopamine concentrations and dopamine transporter

  2001cited by this paper
• Conformational change of Bax: a question of life or death

  2001cited by this paper
• Long Term Lithium Treatment Suppresses p53 and Bax Expression but Increases Bcl-2 Expression

  1999cited by this paper
• The role of glutathione in the regulation of apoptosis

  1999cited by this paper
• Trophic effects of purines in neurons and glial cells.

  1999cited by this paper
• The Mood‐Stabilizing Agents Lithium and Valproate RobustlIncrease the Levels of the Neuroprotective Protein bcl‐2 in the CNS

  1999cited by this paper
• Mitochondria in the life and death of neurons.

  1998cited by this paper
• Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease.

  1997cited by this paper
• Neuropathology of Parkinson's Disease

  1996cited by this paper
• Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.

  1989cited by this paper
• MPTP toxicity: implications for research in Parkinson's disease.

  1988cited by this paper
• MPTP toxicity: implications for research in Parkinson's disease.

  1988cited by this paper
• Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

  1984cited by this paper

• Interactions between Oxidative Stress and Mitochondrial Dysfunction in Parkinson’s Disease: Potential of Natural Antioxidants

  2025cites this paper
• TDCPP and TiO2 NPs aggregates synergistically induce SH-SY5Y cell neurotoxicity by excessive mitochondrial fission and mitophagy inhibition.

  2024cites this paper
• Purine nucleoside phosphorylase as a target to treat age-associated lower urinary tract dysfunction

  2022cites this paper
• 1,5-Anhydro-D-fructose Protects against Rotenone-Induced Neuronal Damage In Vitro through Mitochondrial Biogenesis

  2021cites this paper
• Age-Related Neurometabolomic Signature of Mouse Brain.

  2021cites this paper
• Adenosine A1 and A2A receptors are involved on guanosine protective effects against oxidative burst and mitochondrial dysfunction induced by 6-OHDA in striatal slices

  2021cites this paper
• Recombinant Rv3261 protein of Mycobacterium tuberculosis induces apoptosis through a mitochondrion-dependent pathway in macrophages and inhibits intracellular bacterial growth.

  2020cites this paper
• Dysregulated metabolic pathways in age-related macular degeneration

  2020cites this paper
• Guanosine Protects Against Behavioural and Mitochondrial Bioenergetic Alterations after Mild Traumatic Brain Injury.

  2020cites this paper
• Guanosine protects against Ca2+-induced mitochondrial dysfunction in rats.

  2019cites this paper
• 6‐Hydroxydopamine induces different mitochondrial bioenergetics response in brain regions of rat

  2019cites this paper
• 2',3'-cGMP exists in vivo and comprises a 2',3'-cGMP-guanosine pathway.

  2019cites this paper
• Correction to: Reversal of homocysteine-induced neurotoxicity in rat hippocampal neurons by astaxanthin: evidences for mitochondrial dysfunction and signaling crosstalk

  2018cites this paper
• Reversal of homocysteine-induced neurotoxicity in rat hippocampal neurons by astaxanthin: evidences for mitochondrial dysfunction and signaling crosstalk

  2018cites this paper
• Interested in publishing with us ? Contact book

  2018cites this paper
• Mitochondria-mediated damage to dopaminergic neurons in Parkinson's disease (Review).

  2017cites this paper
• An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition

  2017influential citation
• Enhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction

  2016cites this paper
• The Guanine-Based Purinergic System: The Tale of An Orphan Neuromodulation

  2016cites this paper
• Damage to dopaminergic neurons is mediated by proliferating cell nuclear antigen through the p53 pathway under conditions of oxidative stress in a cell model of Parkinson's disease.

  2016cites this paper
• Oxidative Stress and Parkinson’s Disease: Effects on Environmental Toxicology

  2016cites this paper
• Distribution characteristics of vesicular monoamine transporter in brain of mice with Parkinson disease

  2016cites this paper
• Guanosine and its role in neuropathologies

  2016cites this paper
• Guanonisa reduz a neurotoxicidade e o déficit motor induzido pelo traumatismo cranioencefálico em ratos

  2016cites this paper
• Atorvastatin protects endothelial colony-forming cells against H2O2-induced oxidative damage by regulating the expression of annexin A2

  2015cites this paper
• DSePA Antagonizes High Glucose-Induced Neurotoxicity: Evidences for DNA Damage-Mediated p53 Phosphorylation and MAPKs and AKT Pathways

  2015cites this paper
• 8-hydroxy-Damage to dopaminergic neurons is mediated by proliferating cell nuclear antigen through the p53 pathway under conditions of oxidative stress in a cell model of Parkinson's disease

  year unknowncites this paper